Related Experiment Video
Updated: Mar 25, 2026
07:07
Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
Published on: February 14, 2025
4.0K
Hypoxia Responsive Drug Delivery Systems in Tumor Therapy
Houman Alimoradi, Siddharth S Matikonda, Allan B Gamble
1Department of Pharmacology and Toxicology, University of Otago, Adams Building, 3rd Floor, 18 Frederick street, Dunedin 9016, New Zealand. khaledfg@agu.edu.bh.
Current Pharmaceutical Design
|February 23, 2016
Summary
Hypoxia, or low oxygen, is common in tumors. This review explores advanced drug delivery systems that target these hypoxic tumor environments, improving cancer treatment efficacy and reducing side effects.
Area of Science:
- Oncology
- Biomedical Engineering
- Drug Delivery Systems
Background:
- Solid tumors frequently exhibit hypoxia due to irregular vascularization.
- Hypoxia-specific drug delivery aims to enhance chemotherapy efficacy and minimize systemic toxicity.
- Nanotechnology has enabled the development of novel hypoxia-responsive delivery systems.
Purpose of the Study:
- To review current hypoxia-responsive drug delivery systems for cancer treatment.
- To discuss the limitations of solely oxygen-level-dependent systems.
- To highlight diverse strategies for targeting hypoxic tumor microenvironments.
Main Methods:
- Review of polymeric-based drug delivery systems.
- Exploration of oxygen delivery systems integrated with radiotherapy and chemotherapy.
- Analysis of anaerobic bacteria for gene delivery (e.g., tumor necrosis alpha, hypoxia-inducible transcription factors 1 alpha).
Main Results:
- Several hypoxia-responsive delivery systems are under development.
- Polymeric systems, oxygen delivery, and gene therapy approaches show promise.
- Current systems are evolving beyond simple reliance on low oxygen levels.
Conclusions:
- Hypoxia-responsive drug delivery offers a promising strategy to improve cancer therapy.
- Diverse approaches, including nanotechnology and gene therapy, are being investigated.
- Further research is needed to optimize these systems for clinical application.
More Related Videos
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
94
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
94
02:49Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
01:27Drug Delivery Systems: Different Types
214
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
214
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
107
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
107
01:23Modified-Release Drug Delivery Systems: Classification
248
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
248
02:53Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K